NCT05932602 - AVEIR DR Coverage With Evidence Development (CED) Study | Biotech Hunter

Enrollment

2,812

Participants

Timeline

Start Date

October 31, 2023

Primary Completion Date

May 31, 2029

Study Completion Date

May 31, 2030

Conditions

Cardiac PacemakerArrythmiaBradycardia

Interventions

DEVICE

Aveir DR Leadless Pacemaker System

This study will utilize real-world data from patients implanted with the Aveir DR Leadless Pacemaker System. No device intervention is required in this study.

DEVICE

Dual Chamber Transvenous Pacemaker

This study will utilize real-world data from patients implanted with a dual-chamber transvenous pacemaker as a comparator to the Aveir DR LP system study arm. No device intervention is required in this study.

Trial Locations (1)

91342

RECRUITING

Abbott, Sylmar